Fellowships

• University of Texas Southwestern Medical Center, 1993, Maternal Fetal Medicine

Residency

• University of Texas Southwestern Medical Center, 1991, Obstetrics and Gynecology

Medical Education

• University of Oklahoma College of Medicine, 1997, Obstetrics and Gynecology

Certifications

• American Board of Obstetrics and Gynecology-Maternal Fetal Medicine
• American Board of Obstetrics and Gynecology-Obstetrics and Gynecology

Publications

Please view Dr. L. Laurie Scott’s publications on PubMed.

Professional Organizations

• American College of Obstetricians and Gynecologists
• American Medical Association Society of Maternal-Fetal Medicine
• American Institute of Ultrasound in Medicine

Presentations

• Opioid Use, Screening and Treatment in Pregnancy. Opioid Use Disorder National Safe Table panelist. Envision Healthcare Services. October 2022.
• Mothers in Recovery: BSO Mental Health Summit. Pembroke Pines, Fl. Co-presented with Claudia Vicencio PhD LCSW LMFT. Webinar. Multiple co-presenters. September 2019.
• Alkon J, Schmittner J, and Scott LL. Successful treatment of incessant fetal arrhythmia with Sotalol and Flecainide resolves severe fetal hydrops and delivers a healthy term baby. (#523932) American Institute of Ultrasound in Medicine, Orlando, Fl, April 2019. (withdrawn from presentation due to presenters’ inability to attend the meeting)
• Mothers in Recovery: Memorial Healthcare System’s Experience in Treating Substance Use Disorders in Pregnancy. Keynote address for the Regional Summit: The Opioid Addicted Pregnant Patient and Substance Exposed Neonate, Charlotte, DeSoto, Manatee and Sarasota Counties. Co-presented with Claudia Vicencio PhD LCSW LMFT, and Alberto Augsten PharmD BCPP DABAT. Sarasota, FL. September 13-14, 2018.
• Multidisciplinary Care of the High-Risk OB Patient. 2017 Envision Physician Services National Leadership Meeting, Co-presented with Jean Miles, MD, Bruce Schulman, MD, and Timothy DeSantis, MD. Las Vegas, NV. October 2017.
• Mothers in Recovery: Memorial Healthcare System’s Experience in Treating Substance Use Disorders in Pregnancy. Webinar for American Hospital Association. Hollywood, FL. November 2016. Co-presented with Claudia Vicencio PhD LCSW LMFT, Alberto Augsten PharmD BCPP DABAT, and Tammy Tucker PSYD.
• Perinatal Navigation. LDI Conference. Memorial Healthcare System. Hollywood, Fl. June 2013.
• Perinatal Navigation. AWHOHN District Meeting, Ft. Lauderdale, FL, 2012.
• Pros and Cons of Acyclovir Suppression in Term Pregnancy to Prevent Cesarean - a debate. Infectious Disease Special Interest Group. Society Perinatal Obstetricians 18th Annual Meeting, Miami Beach FL, February 4, 1998.
• Spruance SL, and the Smithkline Beecham Herpes Vaccine Efficacy Study Group. Gender specific efficacy of a prophylactic SBAS4-adjuvanted gD2 subunit vaccine against genital herpes disease: Results of two clinical efficacy trials. ICAAC, Toronto, Canada, September 17-20, 2000.
• Scott LL, Hollier LM, Jackson G, Sanchez PJ, Baum A, Wendel GD. Acyclovir suppression to prevent cesarean delivery after first episode genital herpes simplex infection. (#26) Society of Perinatal Obstetricians 18th Annual Meeting, Miami Beach, FL, February 2-7, 1998.
• Dobson AT, Rogers BB, Scott LL. Prophylactic Acyclovir Prevents Herpes Simplex Acute and Latent Infection in a Newborn Mouse Model. (#) Society for Gynecologic Investigation, San Diego, CA, March 18-22, 1997.
• Scott LL, Dobson AT, Hollier LM, Little BB. Prophylactic acyclovir to prevent neonatal herpes - a murine model. (#74) Society of Perinatal Obstetricians 17th Annual Meeting, Anaheim, CA, January 20-25, 1997.
• Scott LL, Dobson AT, Hollier LM, Little BB. A new model for the study of disseminated neonatal herpes infection. American College of Obstetricians and Gynecologists 1996 District VII Meeting, New Orleans, LA.
• Dobson AT, Scott LL, Little BB. Prevention of herpes simplex virus infection and latency by prophylactic treatment with acyclovir. 4th Annual Texas Ob/Gyn Resident Research, Arlington, TX, June 7, 1996.
• Dobson AT, Scott LL, Little BB. Prevention of herpes simplex virus infection and latency by prophylactic treatment with acyclovir. (#13) Society for Gynecologic Investigation, Philadelphia, PA, March 19-23, 1996.
• Scott L, Sanchez P, Jackson G, Wendel G. Prevention of cesarean section for recurrent genital herpes simplex virus (HSV) using acyclovir suppressive therapy. 1st Annual South-Central Conference on Perinatal Research, Austin, TX, October 6-7, 1994.
• Scott LL, Van Hooser L, Wendel GD. Prevention of cesarean section for recurrent genital herpes simplex virus (HSV) using acyclovir suppressive therapy-Update I. International Herpes Management Forum Workshop on Perinatal and Neonatal Herpes, Prague, Czechoslovakia, April 21-22, 1994.
   

Awards

• “Women in Medicine Month,” Highlighted Physician Envision Healthcare System, 2019
• Spirit of Healing Award, Memorial Healthcare System, 2019
• Honorable Mention, Poster Presentation, Florida Perinatal Quality Collaborative, 3rd Annual Meeting, Tampa, FL, April 3-4, 2014: “The “Hard Stop”: Decreasing Elective Deliveries and NICU Admissions Before 39 Weeks.” Scott LL, Kline Kaye V.
• Best Presentation of Magnolia Session, ACOG District VII Annual Meeting, November 1996: A New Model for the Study of Disseminated Neonatal Herpes Infection. Scott L, Dobson A, Hollier L, Little B. New Orleans, LA
• Fourth Annual Texas OB/GYN Resident Research Award for Best Abstract, 1996: A prevention of herpes simplex virus infection and latency by prophylactic treatment with acyclovir. Dobson A, Scott L, Little B. Ft. Worth, TX
• CREOG Award, 1991